Amplifon Pubblicazione Verbale Assemblea Ordinaria degli Azionisti: directors' dealings · Italy · Consob

About Amplifon Pubblicazione Verbale Assemblea Ordinaria degli Azionisti

Amplifon S.p.A. is an Italian listed company on Borsa Italiana (FTSE MIB), within the Italy market, and one of the global leaders in hearing care solutions and services. Founded in Milan in 1950, the company has built its business model around a broad international network of hearing-care centers, personalized support from hearing specialists, and technology-enabled services designed to improve the customer journey across the full value chain. Its headquarters are in Milan, Italy, making Amplifon a significant benchmark for investors seeking exposure to the consumer health sector. Amplifon’s core business consists of the sale, fitting and follow-up of hearing aids, together with diagnostic services, maintenance, fine-tuning and replacement of devices over time. The group also sells related accessories and consumables used for hearing aid care. Over recent years, Amplifon has strengthened its competitive position through a combination of organic growth, targeted acquisitions and digital innovation. The company reported revenues above EUR 2.4 billion in 2024, supported by above-market organic performance and a faster pace of M&A, including the addition of new points of sale in Europe, the United States and China.([corporate.amplifon.com](https://corporate.amplifon.com/it/investors/highlight-finanziari?utm_source=openai)) From a competitive standpoint, Amplifon stands out for the density of its retail footprint, its proximity-based service model and its ability to deploy omnichannel customer platforms. The group describes itself as a global leader in hearing solutions and services, with a broad geographic presence across Europe, North America, Australia and other developed markets. Its corporate history highlights a gradual international expansion from Italy, as well as its inclusion in the FTSE MIB in 2018.([corporate.amplifon.com](https://corporate.amplifon.com/en/our-identity/about-us/?utm_source=openai)) Recent developments underline a still-expanding but more selective growth profile. In 2025, Amplifon released half-year results in a European market environment that remained weaker than expected and launched the Fit4Growth plan to improve profitability and strengthen competitiveness. In March 2026, the company announced 2025 revenues of EUR 2.4 billion, up 1.7%, and said the strategic plan was being accelerated. On 23 April 2026, shareholders approved the 2025 financial statements and a dividend of EUR 0.29 per share, confirming continued shareholder remuneration.([corporate.amplifon.com](https://corporate.amplifon.com/it/investors/comunicati-stampa/f-cs-risultati-Q2-2025?utm_source=openai)) For international investors, Amplifon offers a defensive healthcare-related profile, diversified global exposure and a leading position in a market supported by demographic aging and the long-term increase in hearing-loss treatment needs.